| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |